RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
VMSGX
Price
$19.80
Change
-$0.09 (-0.45%)
Updated
Sep 20 closing price
Ad is loading...

RPTIX vs VMSGX

Header iconRPTIX vs VMSGX Comparison
Open Charts RPTIX vs VMSGXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
VALIC Company I Mid Cap Strategic Gr
Price$19.80
Change-$0.09 (-0.45%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPTIX vs VMSGX Comparison Chart
Loading...
VS
RPTIX vs. VMSGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a StrongBuy and VMSGX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. VMSGX (1.08B). RPTIX pays higher dividends than VMSGX: RPTIX (0.18) vs VMSGX (0.01). RPTIX was incepted earlier than VMSGX: RPTIX (9 years) vs VMSGX (20 years). VMSGX is a more actively managed with annual turnover of: 67.00 vs. RPTIX (21.70). VMSGX has a lower initial minimum investment than RPTIX: VMSGX (0) vs RPTIX (500000). VMSGX annual gain was more profitable for investors over the last year : 31.93 vs. RPTIX (14.81). VMSGX return over 5 years is better than : 17.75 vs. RPTIX (15.09).
RPTIXVMSGXRPTIX / VMSGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years20 years-
Gain YTD9.12715.80658%
Front LoadN/AN/A-
Min. Initial Investment5000000-
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B1.08B2,899%
Annual Yield % from dividends0.180.011,287%
Returns for 1 year14.8131.9346%
Returns for 3 years-13.57-18.7173%
Returns for 5 years15.0917.7585%
Returns for 10 yearsN/A19.14-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp